GlassScriptPhysician profile
Manuel B Torres
NPI 1326154261
$597.81
in general payments reported to CMS, 2019-2025
14 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.25 · 2022: $46.09 · 2023: $135 · 2024: $89.90 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $86.17 | 2023-2025 | Arexvy, Shingrix |
| Abbott Laboratories | $82.18 | 2025 | Triclip |
| Novartis Pharmaceuticals Corporation | $75.25 | 2024-2025 | |
| Lilly USA, LLC | $60.64 | 2022-2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $57.92 | 2023-2025 | Cologuard Collection Kit |
| Biomerieux INC | $40.79 | 2025 | |
| Eisai INC. | $31.91 | 2025 | |
| Novo Nordisk INC | $31.48 | 2020-2023 | Wegovy |
| Hologic Sales and Service, LLC | $29.80 | 2023 | Horizon A |
| Tempus Ai, INC | $28.78 | 2025 | Xt Cdx |
| Radius Health, INC. | $19.85 | 2023 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.48 | 2022 | |
| Philips North America LLC | $17.68 | 2025 | Igt Devices Undivided |
| Watermark Medical, INC. | $16.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.